These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2685164)

  • 21. [Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy].
    Agabiti-Rosei E
    Drugs; 2003; 63 Spec No 1():19-29. PubMed ID: 12708883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment.
    Schiffrin EL
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1192-200. PubMed ID: 15607629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The vascular changes in arterial hypertension].
    Ponte E; Cafagna D
    Minerva Med; 1995 Sep; 86(9):357-65. PubMed ID: 7501226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiovascular effects of calcium antagonists].
    Pasanisi F; Marino A
    Clin Ter; 1989 Jul; 130(1):3-10. PubMed ID: 2529078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
    Busse R; Bassenge E
    Herz; 1982 Dec; 7(6):388-405. PubMed ID: 6131027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Calcium inhibitors. Principles and rules of use].
    Thuillez C
    Rev Prat; 1993 May; 43(9):1159-66. PubMed ID: 8378729
    [No Abstract]   [Full Text] [Related]  

  • 27. [Regression of biochemical changes in heart muscle hypertrophy].
    Zähringer J
    Z Kardiol; 1985; 74 Suppl 7():119-26. PubMed ID: 2868582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium antagonists in hypertensive disease: experimental evidence for a new therapeutic concept.
    Kazda S; Garthoff B; Luckhaus G
    Postgrad Med J; 1983; 59 Suppl 2():78-83. PubMed ID: 6351044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effect of T-type calcium channel blockers on endothelial function in patients with essential hypertension.
    Oshima T; Ozono R; Yano Y; Higashi Y; Teragawa H; Miho N; Ishida T; Ishida M; Yoshizumi M; Kambe M
    Hypertens Res; 2005 Nov; 28(11):889-94. PubMed ID: 16555577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of nifedipine coat-core and amlodipine on systemic arterial stiffness modulated by sympathetic and parasympathetic activity in hypertensive patients.
    Fukuda M; Masuda T; Ogura MN; Moriya T; Tanaka K; Yamamoto K; Ishii A; Yonezawa R; Noda C; Izumi T
    Hypertens Res; 2009 May; 32(5):392-8. PubMed ID: 19373239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium antagonists for cardiovascular disease.
    Drug Ther Bull; 1993 Oct; 31(21):81-4. PubMed ID: 8269825
    [No Abstract]   [Full Text] [Related]  

  • 32. Calcium-channel blockers for combined systemic hypertension and myocardial ischemia.
    Frishman WH; Charlap S
    Circulation; 1987 Jun; 75(6 Pt 2):V154-62. PubMed ID: 3552312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vasomotor activity in the large arterial vessels and arterial hypertension].
    Laurent S; Safar M
    Arch Mal Coeur Vaiss; 1991 Jan; 84 Spec No 1():59-63. PubMed ID: 2053834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium-channel blockers and systemic hypertension.
    Frishman WH; Charlap S; Ocken S; Spivack C
    J Clin Hypertens; 1985 Jun; 1(2):107-22. PubMed ID: 3915318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac hypertrophy and aortic compliance after calcium channel antagonism in hypertension.
    Pannier BM; Tual JL; Safar ME
    Drugs; 1992; 44 Suppl 1():44-7. PubMed ID: 1283583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current physiopathological concerns in arterial hypertension].
    Pannier BM; London GM; Laurent S; Safar ME
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():23-5. PubMed ID: 2150471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large and small artery cross-talk and recent morbidity-mortality trials in hypertension.
    Laurent S; Briet M; Boutouyrie P
    Hypertension; 2009 Aug; 54(2):388-92. PubMed ID: 19546376
    [No Abstract]   [Full Text] [Related]  

  • 38. Arterial distensibility and left ventricular hypertrophy in patients with sustained essential hypertension.
    Girerd X; Laurent S; Pannier B; Asmar R; Safar M
    Am Heart J; 1991 Oct; 122(4 Pt 2):1210-4. PubMed ID: 1833966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical study of arterial rigidity. Part II. Remodeling of vessels in arterial hypertension and metabolic syndrome. possibilities of correction with drugs].
    Oleĭnikov VE; Matrosova IB
    Kardiologiia; 2009; 49(12):51-7. PubMed ID: 20038283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arterial structural modifications in hypertension. Effects of treatment.
    Thom S
    Eur Heart J; 1997 Nov; 18 Suppl E():E2-4. PubMed ID: 9402464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.